An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
GUILFORD, Conn.--(BUSINESS WIRE)--
May 17, 2022--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the Next-Generation Protein Analysis and Detection Conference, a VIB Tools & Technologies conference, taking place in Ghent, Belgium on May 30-31, 2022.
Brian Reed, Ph.D., Head of Research, will provide an update on the Company’s research and development progress in an oral presentation titled, “Real-time dynamic single-molecule protein sequencing on the Quantum-Si platform,” on Tuesday, May 31, 2022 at 2:40 – 3:05 PM CEST. The presentation abstract is available until August 30, 2022 for registered attendees of the event.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
